NovaBay Pharmaceuticals (NBY) Posts Break Even Q3 Loss
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Research and development: 4K
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Research and development: 4K
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $3.64 million versus the consensus estimate of $3.08 million.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
- UBS Upgrades Mitsubishi Heavy Industries Ltd (7011:JP) (MHVYF) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
